Article
Uncoupling T‐cell expansion from effector differentiation in cell‐based immunotherapy
13 Dec 2013
Abstract excerpt
Adoptive cellular immunotherapy (ACT) is a potentially curative therapy for patients with advanced cancer. Eradication of tumor in mouse models and humans correlates with both a high dose of adoptively transferred cells and cells with a minimally differentiated phenotype that maintain replicative capacity and multipotency. We speculate that response to ACT not only requires transfer of cells with immediate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
